CAPTRUST Financial Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-44,164
| Closed | -$1.38M | – | 2140 |
|
|
2023
Q4 | $1.38M | Sell |
44,164
-21,290
| -33% | -$666K | ﹤0.01% | 1085 |
|
|
2023
Q3 | $1.36M | Buy |
65,454
+1,685
| +3% | +$35.1K | 0.01% | 1024 |
|
|
2023
Q2 | $1.53M | Buy |
+63,769
| New | +$1.53M | 0.01% | 949 |
|
|
2022
Q3 | – | Sell |
-1,051
| Closed | -$15K | – | 2071 |
|
|
2022
Q2 | $15K | Sell |
1,051
-1,133
| -52% | -$16.2K | ﹤0.01% | 3519 |
|
|
2022
Q1 | $53K | Buy |
2,184
+103
| +5% | +$2.5K | ﹤0.01% | 2739 |
|
|
2021
Q4 | $49K | Buy |
2,081
+1,268
| +156% | +$29.9K | ﹤0.01% | 2682 |
|
|
2021
Q3 | $14K | Sell |
813
-1,381
| -63% | -$23.8K | ﹤0.01% | 3387 |
|
|
2021
Q2 | $54K | Sell |
2,194
-349
| -14% | -$8.59K | ﹤0.01% | 2463 |
|
|
2021
Q1 | $66K | Buy |
2,543
+758
| +42% | +$19.7K | ﹤0.01% | 2240 |
|
|
2020
Q4 | $95K | Buy |
+1,785
| New | +$95K | ﹤0.01% | 1525 |
|
|
2020
Q3 | – | Sell |
-150
| Closed | -$8K | – | 3034 |
|
|
2020
Q2 | $8K | Buy |
+150
| New | +$8K | ﹤0.01% | 2244 |
|
|
2019
Q3 | – | Sell |
-350
| Closed | -$9K | – | 1920 |
|
|
2019
Q2 | $9K | Hold |
350
| – | – | ﹤0.01% | 1517 |
|
|
2019
Q1 | $9K | Hold |
350
| – | – | ﹤0.01% | 1402 |
|
|
2018
Q4 | $6K | Sell |
350
-367
| -51% | -$6.29K | ﹤0.01% | 1300 |
|
|
2018
Q3 | $15K | Sell |
717
-298
| -29% | -$6.23K | ﹤0.01% | 1097 |
|
|
2018
Q2 | $15K | Buy |
1,015
+565
| +126% | +$8.35K | ﹤0.01% | 1038 |
|
|
2018
Q1 | $9K | Sell |
450
-100
| -18% | -$2K | ﹤0.01% | 1041 |
|
|
2017
Q4 | $17K | Buy |
550
+200
| +57% | +$6.18K | ﹤0.01% | 833 |
|
|
2017
Q3 | $10K | Buy |
+350
| New | +$10K | ﹤0.01% | 432 |
|